Oxford Biomedica (LON:OXB) Shares Cross Above 200-Day Moving Average – Should You Sell?

Posted by Cynthia Vaughn on Nov 2nd, 2024

Oxford Biomedica plc (LON:OXB – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 336.94 ($4.37) and traded as high as GBX 405.50 ($5.26). Oxford Biomedica shares last traded at GBX 405 ($5.25), with a volume of 150,001 shares.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Oxford Biomedica from GBX 250 ($3.24) to GBX 380 ($4.93) and gave the company a “hold” rating in a research report on Tuesday, September 24th.

Get Our Latest Report on OXB

Oxford Biomedica Trading Up 1.8 %

The company has a 50-day moving average price of GBX 370.86 and a 200-day moving average price of GBX 336.94. The firm has a market capitalization of £426.71 million, a price-to-earnings ratio of -281.25 and a beta of 1.09. The company has a debt-to-equity ratio of 154.88, a quick ratio of 1.67 and a current ratio of 2.35.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.